Skip to main content

Ransomware victim disclosure

← All victims

idi pharma

Claimed by Deadlock · listed 5 hours ago

Today
Age
since listed · data leaked

Status timeline

  1. ListedOct 9, 2026
  2. Data leakeddate unknown

At a glance

Status
Data leaked
Country
Spain
Listed on leak site
Oct 9, 2026

About the victim

AI dossier — public-source company profile

idi pharma is an Italian pharmaceutical company based in Aci Bonaccorsi (Sicily) specializing in research and development of innovative nutraceuticals and medical devices. The company focuses on patented formulations and proprietary dosage technologies targeting fertility, urology, gynecology, and sexual health, with a mission to improve patient quality of life through high-quality therapeutic solutions.

Industry
Pharmaceutical Research & Development – Nutraceuticals and Medical Devices
Address
Via Goffredo Mameli, 12, 95020 Aci Bonaccorsi CT, Italy

Attack summary

Severity: medium — Data has been published by the threat actor (disclosed_status = data_published), confirming exfiltration. However, no specific data types are detailed in the leak post, no proof files are advertised, and the healthcare sector classification alone (without confirmation of PII, patient records, or regulatory data) does not elevate to 'critical'. Medium reflects confirmed data publication without detailed evidence of sensitive regulated data.

Deadlock claims to have exfiltrated data from idi pharma. The leak post does not specify the scope of data theft (encryption, exfiltration, or both) or itemize what confidential information was taken.

medium

What the group claims

idi pharma is an Italian pharmaceutical company specializing in the research and development of innovative nutraceuticals and medical devices. The company focuses on formulations covered by patents and unique dosage technologies to improve patient health and quality of life (but their data leak).

Sources

Source

Indexed 5 hours ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About Deadlock

Deadlock is a ransomware group first observed in June 2026 with an apparent financial motivation, having claimed responsibility for attacks against at least 10 known victims across a geographically diverse target set. Given the recency of their emergence and limited public documentation by major threat intelligence organizations such as CISA, FBI, or Mandiant at this time, a comprehensive technical profile cannot be fully established. Based on available victimology data, the group has demonstrated a targeting pattern spanning Singapore, China, Sweden, Spain, and Nigeria, suggesting an opportunistic or globally distributed operational scope rather than a regionally focused campaign. Targeted sectors include manufacturing, business services, telecommunications, and financial services, indicating a preference for industries with high operational dependencies and potential for significant disruption, which is consistent with financially motivated ransomware actors seeking maximum leverage for ransom payment. No confirmed attribution regarding country of origin, RaaS affiliation, or specific tooling has been publicly documented by authoritative sources as of this profile's preparation. Due to the group's nascent operational timeline and the limited volume of publicly verified intelligence, analysts should treat this profile as preliminary and subject to significant revision as additional technical indicators, victim disclosures, and research reporting become available. Continued monitoring is advised given the cross-sector and cross-regional targeting behavior observed in this early operational phase. The group has been linked to 132 public disclosures across our corpus. First observed on a leak site on June 15, 2026; most recent post October 10, 2026. The operation is currently active.

Timeline of this disclosure

  • October 9, 2026idi pharma listed by Deadlock on the group's public leak site

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,610 disclosures indexed across all operators we track. Geographically, idi pharma is reported in Spain, a country with 129 ransomware disclosures in our corpus.

If your organisation is affected

A listing by Deadlock means idi pharma appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Report the incident to your national CERT, INCIBE-CERT (Spain), as required for your jurisdiction.
  • Monitor for the data appearing on Deadlock's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.